Zdrowie i gospodarka · 18/10/2000
FDA Grants Exemption for Triiodothyronine Test System
The FDA is publishing an order granting a petition to exempt the triiodothyronine test system from premarket notification requirements, allowing it to measure triiodothyronine in serum and plasma, with certain limitations.
Source: Federal Register — Food and Drug AdministrationOpen original release →